Davern Capital Partners »

Ionis Pharmaceuticals shares owned by Davern Capital Partners

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Davern Capital Partners from 13F filings

Historical chart of Davern Capital Partners investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Davern Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Davern Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $19M 239k 79.11

More positions owned by Davern Capital Partners

Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Biontech Se Sponsored Ads (BNTX)
Royalty Pharma Shs Class A (RPRX)
Argenx Se Sponsored Adr (ARGX)
Legend Biotech Corp Sponsored Ads (LEGN)
Roivant Sciences SHS (ROIV)
Ionis Pharmaceuticals (IONS)
Natera (NTRA)
Eli Lilly & Co. (LLY)
Miragen Therapeutics (VRDN)
Mineralys Therapeutics (MLYS)
Cg Oncology (CGON)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Davern Capital Partners

Top funds holding Ionis Pharmaceuticals

FMR
Vanguard Group
T. Rowe Price Investment Management
Capital World Investors
BlackRock
Wellington Management Company
Lombard Odier Asset Management
Bellevue Group
State Street Corporation
Deep Track Capital
Geode Capital Management
Tweedy, Browne Company
Citadel Advisors
Two Sigma Advisers
Deerfield Management Company

View all funds holding Ionis Pharmaceuticals